Ani Pharmaceuticals (ANIP) Non Operating Interest Expenses (2010 - 2013)
Ani Pharmaceuticals' Non Operating Interest Expenses came in at $98.00 for Q4 2013, down 99.9% from $87,863 a year earlier.
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Non Operating Interest Expenses (2010 - 2013) Analysis & Trends
For FY2013, Ani Pharmaceuticals' Non Operating Interest Expenses was $467,000, down 64.8% from FY2012.
- Non Operating Interest Expenses carries a four-year compound annual growth rate of 33.5% (FY2009 to FY2013).
- Going back by year, Non Operating Interest Expenses was $1.33 million in FY2012 (+94.7%), $681,573 in FY2011 (-0.9%), $688,083 in FY2010 (+368.0%) and $147,025 in FY2009.
- The Q4 2013 figure represents the lowest quarterly Non Operating Interest Expenses in data going back to Q2 2010.
- Year-over-year, Non Operating Interest Expenses increased in 1 of the last seven quarters, with an average decline of 12.4%.
- The fastest year-over-year change in Non Operating Interest Expenses over five years came in Q2 2012 (growth of 191.3%), and the weakest in Q4 2013 (a decline of 99.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | - |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | -477.00 Mn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 653.00 Mn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 269.00 Mn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | - |
| 10 | Ani Pharmaceuticals | 1.43 Bn | 212.92 Mn | 165.89 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2013 | 98.00 |
| Jun 30, 2013 | 374,476.00 |
| Mar 31, 2013 | 93,000.00 |
| Dec 31, 2012 | 87,863.00 |
| Sep 30, 2012 | 81,225.00 |
| Jun 30, 2012 | 501,002.00 |
| Mar 31, 2012 | 124,196.00 |
| Dec 31, 2011 | 165,573.00 |
| Sep 30, 2011 | 172,000.00 |
| Jun 30, 2011 | 172,000.00 |
| Mar 31, 2011 | 172,000.00 |
| Dec 31, 2010 | 172,000.00 |
| Sep 30, 2010 | 172,000.00 |
| Jun 30, 2010 | 172,083.00 |
API Access
Ani Pharmaceuticals Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ANIP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();